Sofwave Medical Ltd. announced the allowance of a second patent by the U.S. Patent and Trademark Office. The allowance grants additional U.S. patent protection for key feature sets of the Company's proprietary SUPERBâ„¢? ("Synchronous Ultrasound Parallel Beam") technology.

This second patent allowance is in addition to Sofwave's existing issued IP in China, HK, Australia and Israel. The Company has an additional 31 patents pending globally and continues to focus on further building the IP around its transformative technology. This second patent allowance is in addition to Sofwave’s existing issued IP in China, HK, Australia and Israel.

The Company has an additional 31 patents pending globally and continues to focus on further building the IP around its transformative technology.